2017
DOI: 10.1590/1806-9282.63.03.224
|View full text |Cite
|
Sign up to set email alerts
|

Genotype 1 of human parvovirus B19 in clinical cases

Abstract: Introduction: Virus surveillance strategies and genetic characterization of human parvovirus B19 (B19V) are important tools for regional and global control of viral outbreak. In São Paulo, Brazil, we performed a study of B19V by monitoring the spread of this virus, which is an infectious agent and could be mistakenly reported as a rash and other types of infection. Method: Serum samples were subjected to enzyme immunoassay, real time polymerase chain reaction, and sequencing. Results: From the 462 patients wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 21 publications
0
4
0
1
Order By: Relevance
“…There are three recognized genotypes of B19V (1, 2, and 3), segregated into subtypes 1a, 1b, 2, 3a, and 3b [4,[33][34][35]. All three genotypes have been reported in both symptomatic and asymptomatic persons, and no association has been established between genotype and clinical manifestations [36][37][38][39][40][41]. Genotype 1 is the most prevalent in the world.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…There are three recognized genotypes of B19V (1, 2, and 3), segregated into subtypes 1a, 1b, 2, 3a, and 3b [4,[33][34][35]. All three genotypes have been reported in both symptomatic and asymptomatic persons, and no association has been established between genotype and clinical manifestations [36][37][38][39][40][41]. Genotype 1 is the most prevalent in the world.…”
Section: Discussionmentioning
confidence: 99%
“…There was a greater number of cases in 2017 and 2018, having decreased in 2019, rising again in 2020, and decreasing again in 2021 and 2022, with a positivity percentage of 20.7%, 13.75%, 8.8 %, 18.3%, 2.3% and 3.4% respectively (Table 1; Figures 3 and 4A). However, further studies are needed over a longer period, since the cycle can last from 4 to 5 years [46]. Additionally, as three years of the study overlapped with the COVID-19 pandemic, this may also have influenced the dynamics of circulation and transmission of B19V.…”
Section: Discussionmentioning
confidence: 99%
“…The Parvovirus B19 complete genome was recovered from the CSF and the genotypic showed, through phylogeny, sequences similar to B19 genotype 1. Genotype 1 is more prevalent in most parts of the world including Brazil [12,13], [46][47][48][49][50], showing a close relationship with the American sequence (Genebank #FJ591158). The other Brazilian sequences available in the reconstructions were relatively distant, suggesting a distant ancestor.…”
Section: Discussionmentioning
confidence: 99%
“…The Parvovirus B19 complete genome was recovered from the CSF and the genotypic showed, through phylogeny, sequences similar to B19 genotype 1. Genotype 1 is more prevalent in most parts of the world including Brazil [ 12 , 13 , 50 , 51 , 52 , 53 , 54 , 55 , 56 ], showing a close relationship with the Netherlands sequence (Genebank #JN211136). The other Brazilian sequences available in the reconstructions were relatively distant, suggesting a distant ancestor.…”
Section: Discussionmentioning
confidence: 99%